These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 21397755)
21. Bradycardia due to cholinesterase inhibitors: identify adverse effects and take them into account. Prescrire Int; 2011 Apr; 20(115):95. PubMed ID: 21648211 [TBL] [Abstract][Full Text] [Related]
22. Sinus arrest as a result of rivastigmine in an elderly dementia with Lewy bodies patient. Muto S; Kawano H; Nakatomi D; Yamasa T; Maemura K Geriatr Gerontol Int; 2015 Feb; 15(2):229-30. PubMed ID: 25619267 [No Abstract] [Full Text] [Related]
23. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients. Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941 [TBL] [Abstract][Full Text] [Related]
24. [Efficacy and safety of rivastigmine (exelon) in the confusion syndrome in the acute phase of ischemic stroke]. Litvineneko IV; Odinak MM; Khlystov IuV; Perstnev SV; Fedorov BB Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(11 Pt 2):36-41. PubMed ID: 21389938 [TBL] [Abstract][Full Text] [Related]
25. Rivastigmine patches: line extension. No therapeutic advantage and less convenient than capsules. Prescrire Int; 2009 Feb; 18(99):19. PubMed ID: 19391277 [No Abstract] [Full Text] [Related]
28. Cholinesterase inhibitors and delirium after cardiac surgery. Yazigi A; Madi-Jebara S; Haddad F; Hayek G Crit Care Med; 2010 Apr; 38(4):1231. PubMed ID: 20335721 [No Abstract] [Full Text] [Related]
29. Risperidone and rivastigmine and agitated behaviour in severe Alzheimer's disease: a randomised double blind placebo controlled study. Holmes C; Wilkinson D; Dean C; Clare C; El-Okl M; Hensford C; Moghul S Int J Geriatr Psychiatry; 2007 Apr; 22(4):380-1. PubMed ID: 17380475 [No Abstract] [Full Text] [Related]
30. Risk factors for nursing home placement in Alzheimer's disease: a longitudinal study of cognition, ADL, service utilization, and cholinesterase inhibitor treatment. Wattmo C; Wallin AK; Londos E; Minthon L Gerontologist; 2011 Feb; 51(1):17-27. PubMed ID: 20562471 [TBL] [Abstract][Full Text] [Related]
31. Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity. Leikin JB; Braund V; DesLauris C Am J Emerg Med; 2014 Jul; 32(7):815.e3-4. PubMed ID: 24589024 [TBL] [Abstract][Full Text] [Related]